Menu
Back to Journals » Cancer Management and Research » Volume 10
Review
Evolution of regorafenib from bench to bedside in colorectal cancer: Is it an attractive option or merely a “me too” drug?
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 19,722 | Dovepress* | 16,357+ | 1,783 | 18,140 | |
| PubMed Central* | 3,365 | 712 | 4,077 | ||
| Totals | 19,722 | 2,495 | 22,217 | ||
| *Since 6 March 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 2 | 6 |
View citations on PubMed Central and Google Scholar